2014 Sales of Recombinant Therapeutic Antibodies & Proteins
2014 Sales of Recombinant Therapeutic Antibodies & Proteins
This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2014. Sales data were obtained from company publications and refer to branded products originating from companies based in regulated markets. All sales data were converted from their original, published currency into US$ using official currency exchange rates as of March 17, 2015. Sales figures represent the sum of revenues in all territories where the products are marketed and are mostly presented either after hedging.
Sales data are presented for each product within the respective class of biologics. The data were analyzed to establish a ranking list of blockbuster biologics with 2014 sales higher than US$ 1 bln. Another ranking list was prepared for companies according to biologics sales in 2014 and the percentage of antibody sales vs protein sales.
This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2014. Sales data were obtained from company publications and refer to branded products originating from companies based in regulated markets. All sales data were converted from their original, published currency into US$ using official currency exchange rates as of March 17, 2015. Sales figures represent the sum of revenues in all territories where the products are marketed and are mostly presented either after hedging.
Sales data are presented for each product within the respective class of biologics. The data were analyzed to establish a ranking list of blockbuster biologics with 2014 sales higher than US$ 1 bln. Another ranking list was prepared for companies according to biologics sales in 2014 and the percentage of antibody sales vs protein sales.
2014 BIOLOGICS SALES PER CLASS OF PRODUCTS
Blockbuster Biologics in 2014 (by generic name)
Company Ranking List for Biologics Sales 2014
Biologic Product Sales 2014
Anti-TNF Antibodies
Cancer Antibodies
Insulin and Insulin Analogs
Anti-Inflammatory and Anti-Autoimmune Antibodies
Recombinant Coagulation Factors
Ophthalmic Antibodies
Erythropoietins
Interferon beta
G-CSF
Enzyme Replacement Proteins
Human Growth Hormone
Interferon alpha
Follicle Stimulating Hormone
Cardiometabolic & Anti-Infective Antibodies
Other Proteins: Cardiometabolic, Cancer & Others
Blockbuster Biologics in 2014 (by generic name)
Company Ranking List for Biologics Sales 2014
Biologic Product Sales 2014
Anti-TNF Antibodies
Cancer Antibodies
Insulin and Insulin Analogs
Anti-Inflammatory and Anti-Autoimmune Antibodies
Recombinant Coagulation Factors
Ophthalmic Antibodies
Erythropoietins
Interferon beta
G-CSF
Enzyme Replacement Proteins
Human Growth Hormone
Interferon alpha
Follicle Stimulating Hormone
Cardiometabolic & Anti-Infective Antibodies
Other Proteins: Cardiometabolic, Cancer & Others
